ArticlebioRxiv : the preprint server for biology2026
Interpretable Antibody-Antigen Structural Interface Prediction via Adaptive Graph Learning and Cyclic Transfer.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Experimental structural methods can identify antibody-antigen interfaces with high precision, but they remain time-consuming and resource-intensive, limiting their application across the rapidly expanding space of antibody and antigen sequences. Computational models capable of predicting these interfaces could therefore accelerate antibody discovery and provide insight into the principles governing immune recognition. However, this problem remains challenging due to limited structural datasets, severe class imbalance, and the complex, non-local nature of biomolecular interactions. Here we present VASCIF (Variable-domain Antibody-antigen Structural Complex Interface Finder), a structure-aware framework built on a Masked Graph Attention (MGA) architecture that represents protein complexes as residue graphs and captures long-range structural dependencies through attention-based message passing. The framework is straightforward to implement and enables efficient inference, allowing substantially faster predictions than other existing structure-based approaches. Evaluated on curated structural complexes across multiple benchmark datasets using rigorous cross-validation, VASCIF achieves state-of-the-art performance for residue-level interface prediction. Interpretability analyses reveal that the model recovers biophysically meaningful interaction patterns consistent with known principles of antibody recognition, and redefining interfaces using larger residue distance thresholds (~10 Å) significantly improves predictive performance. Together, VASCIF provides a practical predictive framework and new insights into antibody-antigen molecular recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.